Last reviewed · How we verify

NCT05322993

Improving Polyp Detection Rate by Artificial Intelligence in Colonoscopy

Completed NA Last updated 22 January 2026
What this trial tests

NA trial testing GI Genius in Colonic Polyp in 5,034 participants. Completed in 30 June 2025.

Timeline
19 November 2021
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorHaraldsplass Deaconess Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposediagnostic
Enrollment5,034
Start date19 November 2021
Primary completion30 June 2025
Estimated completion30 June 2025
Sites3 locations across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Haraldsplass Deaconess Hospital

Who can join

Eligibility, any sex, with Colonic Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate if the use of artificial intelligence (AI) in colonoscopy improves the polyp detection rate, and if the use of AI has a learning effect.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of GI Genius

Trials testing the same drug.

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

Other Haraldsplass Deaconess Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05322993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing